true
Singapore – BD receives the prestigious National Award (COVID-19)
Publish date:
Aug 14, 2023
BD Integrated Diagnostic Solutions (IDS) proudly received the Singapore President’s Certificate of Commendation from President Halimah Yacob at the National Awards (COVID-19) Investiture on June 18, 2023. This award has been granted to organizations and teams that made exceptional efforts which had a significant impact in Singapore’s fight against COVID-19.
During COVID-19, Singapore was looking for solutions to open its borders (air, sea, land) for business and tourism to flow, to get people’s lives back to normal, and support local businesses. Pre-pandemic, over 10,000 trucks crossed the land border between Singapore and Malaysia daily, transporting essential goods vital to both economies. The Singapore government needed a screening solution for drivers and an approach to share results among authorities, linking data to Singapore’s COVID track and trace technologies.
Shinya Nagase, Vice President, Integrated Diagnostic Solutions, Central Asia, South Asia, Japan (left), with Singapore Minister for Health Ong Ye Kung (right).
BD partnered with the Government of Singapore and health care providers to create an end-to-end solution for rapid COVID-19 registration, testing, reporting, and monitoring at its borders. BD’s Veritor™ Rapid Antigen Test was a core technology adopted, providing fast and easy-to-use testing for SARS-CoV-2 in a time-sensitive and dynamic setting at land border checkpoints. The collaboration also included the development of unique workflows and digital connectivity, scientific partnership with academic institutions, and policy dialogue with decision makers on testing strategies. This partnership facilitated the reopening of borders, enabled supply chain continuity, and supported livelihoods and economic activity.
In Singapore and around the world, BD stands ready to provide support and continued access to critical healthcare products during pandemics and into the future.
12 BD associates have also been awarded the Public Service Medal (COVID-19) for their courage and dedication in working hand in hand with the Government of Singapore and health care providers in the fight against COVID-19. They are:
Caitlin Asjes; Chow Liang Wui, Raymond; Hui Eng Leong, James; Lim Leong Ching, James; Lim Xiu Hui; Viva Ma; Paul Chua; Shinya Nagase; Sng Lee Hwuang, Pauline; Tan Kok Hui; Tan Yen Lin; Yap Beng Eng, Leslie.
About BD in Singapore
BD was established in Singapore in 1987. The company moved its Asia Pacific Headquarters from Hong Kong to Singapore in 1989 and was one of the first global medical technology companies to commence manufacturing in Singapore. BD Singapore has two sites and currently employs close to 1,400 staff across both locations.
Becton Dickinson Holdings Pte Ltd (“BDH”) at 2 International Business Park Road houses BD’s Greater Asia and South-East Asia headquarters, with functions such as management, marketing, sales, finance, and procurement to support BD’s operations in the region.
Becton Dickinson Medical (S) Pte Ltd (“BDM”), at 30 Tuas Ave 2, spanning 61,000 sqm houses the company’s manufacturing operations, and is BD’s R&D control tower for Asia and several shared services functions for the region. BD Singapore is currently the company’s largest global manufacturing facility in Greater Asia by manufacturing output. BD has continued to invest manufacturing capacity and upgrades in Singapore. Over the past decade, BD has invested US$269M in continued upgrades to manufacturing operations. BD is engaged with the Singapore EDB in the Industry 4.0 Strategy and is committed to building a factory of the future, focusing on upskilling our workforce, integrating new technology, and optimizing our processes.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BdandCo.
true
